#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Noonan syndrome Short stature Transplant rejection Liver abscess Gaucher's disease type III Neuroendocrine tumour Homocystinuria Spinal muscular atrophy Stiff person syndrome Hyperphagia Amyotrophic lateral sclerosis gene carrier Prodromal Alzheimer's disease Barth syndrome Deafness Myocarditis More trials…

    Learn about Rare Diseases

    Hereditary optic atrophy – Basic Information Inclusion body myositis – Life with Disease Primary hyperoxaluria – Basic Information Atypical haemolytic uraemic syndrome Hyperoxaluria – Treatment Alagille syndrome – Basic Information Rhabdomyosarcoma Stevens-Johnson syndrome – Life with Disease Mastocytosis – Trials in Disease Paraneoplastic neurological syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Iph5201 Eptinezumab HTL0022537 Captopril ATIRMOCICLIB Denosumab Vrdn-001 Enpatoran Rmc-035 SULBACTAM SODIUM Amikacin Bevacizumab Setrusumab Allopurinol Sodium GRNA-001 Ruxolitinib Temocillin Belzutifan Dc-806 Rifapentine More therapies…

    Learn about Your Condition

    Haemodialysis Breast cancer female Urea cycle disorder B-cell lymphoma Propionic acidaemia Genital infection female Von Hippel-Lindau disease Stomatitis Pleural mesothelioma Cerebral palsy Salivary gland cancer Biotinidase deficiency Infertility Skin ulcer Cytokine release syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Fallopian tube cancer

  • Study on Bevacizumab Dose Equivalence for Patients with Ovarian, Fallopian Tube, or Peritoneal Cancer Using Bevacizumab, Olaparib, Carboplatin, and Paclitaxel

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Fallopian tube cancer
    • Malignant peritoneal neoplasm
    • Ovarian cancer
    Investigated Drugs:
    • Bevacizumab
    • Carboplatin
    • Olaparib
    Poland

  • Study of Mirvetuximab Soravtansine and Bevacizumab for Maintenance in Adults with Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Fallopian tube cancer
    • Ovarian epithelial cancer
    Investigated Drugs:
    • Mirvetuximab Soravtansine
    • Propylene Glycol
    • Bevacizumab
    Belgium Bulgaria Czechia France Germany Greece +5

  • Study of Relacorilant and Nab-Paclitaxel for Patients with Advanced, Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Relacorilant
    • Paclitaxel Albumin-Bound
    Belgium France Hungary Italy Poland Spain

  • Study on the Safety and Effectiveness of IMGN151 for Women with Recurrent Endometrial and Ovarian Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Cervix carcinoma recurrent
    • Endometrial cancer recurrent
    • Fallopian tube cancer
    Investigated Drugs:
    • Brimonidine Tartrate
    • Imgn151
    • Prednisolone Acetate
    Belgium France Germany Ireland Italy The Netherlands +1

  • Study of Nemvaleukin Alfa and Pembrolizumab for Patients with Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer.

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Peritoneal cancer index
    • Fallopian tube cancer
    • Ovarian cancer
    Investigated Drugs:
    • Nemvaleukin Alfa
    • Doxorubicin Hydrochloride
    • Gemcitabine Hydrochloride
    Austria Belgium Czechia Denmark France Germany +4

  • Study on Mirvetuximab Soravtansine and Carboplatin for Patients with Recurrent Ovarian Cancer Eligible for Platinum-Based Chemotherapy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Fallopian tube cancer metastatic
    • Ovarian cancer metastatic
    • Ovarian cancer recurrent
    Investigated Drugs:
    • Mirvetuximab Soravtansine
    • Doxorubicin Hydrochloride, Liposomal
    • Rucaparib
    Germany
Previous Page
1 2 3 4 5
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!